Literature DB >> 32410904

Prevalence of Lower Urinary Tract Symptoms in People with Multiple Sclerosis: A Systematic Review and Meta-analysis.

Hawra B Al Dandan, Susan Coote, Doreen McClurg.   

Abstract

BACKGROUND: No published study, to our knowledge, has systematically reviewed the prevalence estimates of lower urinary tract symptoms (LUTSs) and LUTS types in the general multiple sclerosis (MS) population. Therefore, a systematic review and a meta-analysis were conducted to determine the totality of literature investigating the prevalence of LUTSs and LUTS types in the general MS population according to International Continence Society definitions.
METHODS: Various electronic databases were searched between January 4, 2018, and February 12, 2018. This review included observational studies involving adults (18 years or older) with a confirmed diagnosis of MS recruited from the general MS population using self-report and/or objective outcome measures for LUTSs.
RESULTS: Twelve studies were included in the meta-analysis. The results showed that LUTSs were prevalent in people with MS, with a pooled prevalence of 68.41% using self-report and 63.95% using the objective measure of urodynamics. When considering LUTS types, urinary frequency was the predominant symptom, with a pooled prevalence estimate of 73.45%, followed by urgency assessed using self-report measures at 63.87%. Detrusor overactivity was found to be the most prevalent urodynamic symptom, with a pooled prevalence estimate of 42.9%, followed by detrusor sphincter dyssynergia at 35.44%.
CONCLUSIONS: This systematic review revealed that LUTSs are highly prevalent in MS. There is a need for improvement in the conduct and reporting of prevalence studies of LUTSs in MS and for the use of validated self-report outcome measures to enable pooling of data in the future.
© 2020 Consortium of Multiple Sclerosis Centers.

Entities:  

Keywords:  Multiple sclerosis (MS); Neurogenic bladder; Overactive bladder; Urinary tract symptoms

Year:  2020        PMID: 32410904      PMCID: PMC7204365          DOI: 10.7224/1537-2073.2019-030

Source DB:  PubMed          Journal:  Int J MS Care        ISSN: 1537-2073


  53 in total

Review 1.  Measuring inconsistency in meta-analyses.

Authors:  Julian P T Higgins; Simon G Thompson; Jonathan J Deeks; Douglas G Altman
Journal:  BMJ       Date:  2003-09-06

2.  Prevalence of autonomic dysfunction in patients with multiple sclerosis.

Authors:  Bitia Vieira; Andreia Costa; Gonçalo Videira; Maria José Sá; Pedro Abreu
Journal:  Acta Med Port       Date:  2015-02-27

3.  Reduced quality of life among multiple sclerosis patients with sexual disturbance and bladder dysfunction.

Authors:  M W Nortvedt; T Riise; K M Myhr; A M Landtblom; A Bakke; H I Nyland
Journal:  Mult Scler       Date:  2001-08       Impact factor: 6.312

4.  Predictability of urodynamic findings based on the Urogenital Distress Inventory-6 questionnaire.

Authors:  G E Lemack; P E Zimmern
Journal:  Urology       Date:  1999-09       Impact factor: 2.649

5.  Urinary tract dysfunction in multiple sclerosis: is there a relation with disease-related parameters?

Authors:  D Porru; G Campus; A Garau; M Sorgia; A C Pau; G Spinici; M P Pischedda; M G Marrosu; R M Scarpa; E Usai
Journal:  Spinal Cord       Date:  1997-01       Impact factor: 2.772

6.  Urinary incontinence in multiple sclerosis: prevalence, severity and impact on patients' quality of life.

Authors:  C Zecca; G C Riccitelli; G Disanto; A Singh; G A Digesu; L Panicari; F Puccini; M Mattioli; A Tubaro; C Gobbi
Journal:  Eur J Neurol       Date:  2016-04-27       Impact factor: 6.089

Review 7.  Systematic review of the epidemiology of urinary incontinence and detrusor overactivity among patients with neurogenic overactive bladder.

Authors:  Alain Ruffion; David Castro-Diaz; Hetal Patel; Kristin Khalaf; Ahunna Onyenwenyi; Denise Globe; Corinne Lereun; Mamuka Teneishvili; Meredith Edwards
Journal:  Neuroepidemiology       Date:  2013-08-08       Impact factor: 3.282

8.  Assessment of autonomic nervous system dysfunction in multiple sclerosis and association with clinical disability.

Authors:  Nilufer Kale; Setty Magana; Jale Agaoglu; Osman Tanik
Journal:  Neurol Int       Date:  2009-11-16

9.  Prevalence of stress urinary incontinence in women with multiple sclerosis.

Authors:  Alana M Murphy; Francois Bethoux; Darlene Stough; Howard B Goldman
Journal:  Int Neurourol J       Date:  2012-06-30       Impact factor: 2.835

10.  Urinary dysfunction in women with multiple sclerosis: analysis of 61 patients from rio de janeiro, Brazil.

Authors:  Camila Rodrigues de Almeida; Kennedy Carneiro; Rossano Fiorelli; Marco Orsini; Regina Maria Papais Alvarenga
Journal:  Neurol Int       Date:  2013-11-11
View more
  4 in total

1.  CoachMS, an innovative closed-loop, interdisciplinary platform to monitor and proactively treat MS symptoms: A pilot study.

Authors:  Valerie J Block; Arpita Gopal; William Rowles; Chu -Yueh; Jeffrey M Gelfand; Riley Bove
Journal:  Mult Scler J Exp Transl Clin       Date:  2021-02-02

2.  Feasibility and acceptability of transcutaneous tibial nerve stimulation for the treatment of bladder storage symptoms among people with multiple sclerosis.

Authors:  Hawra B Al Dandan; Rose Galvin; Katie Robinson; Doreen McClurg; Susan Coote
Journal:  Pilot Feasibility Stud       Date:  2022-07-30

3.  The Impact of Neurogenic Lower Urinary Tract Symptoms and Erectile Dysfunctions on Marital Relationship in Men with Multiple Sclerosis: A Single Cohort Study.

Authors:  Riccardo Bientinesi; Simone Coluzzi; Filippo Gavi; Viviana Nociti; Carlo Gandi; Filippo Marino; Stefano Moretto; Massimiliano Mirabella; PierFrancesco Bassi; Emilio Sacco
Journal:  J Clin Med       Date:  2022-09-24       Impact factor: 4.964

Review 4.  Neurological Benefits, Clinical Challenges, and Neuropathologic Promise of Medical Marijuana: A Systematic Review of Cannabinoid Effects in Multiple Sclerosis and Experimental Models of Demyelination.

Authors:  Victor Longoria; Hannah Parcel; Bameelia Toma; Annu Minhas; Rana Zeine
Journal:  Biomedicines       Date:  2022-02-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.